跳至主要内容
临床试验/NCT06527157
NCT06527157招募中不适用

PROspective ACcrual To Investigate reprOductive Cancers in womeN

PinkDx, Inc.27 个研究点 分布在 1 个国家目标入组 4,500 人开始时间: 2024年7月30日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
PinkDx, Inc.
入组人数
4,500
试验地点
27
主要终点
Sensitivity

研究概览

简要总结

The goal of this study is to create a non-invasive diagnostic test to rule out gynecological cancer in females aged 45 and older with abnormal uterine or postmenopausal bleeding.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
45 Years 至 100 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Evidence of a personally signed and dated informed consent form indicating that the subject has been informed of all pertinent aspects of the study.
  • Willing and able to comply with scheduled visits, study plan, and other procedures.
  • Expected to be available for the duration of the study and can be contacted by telephone during study participation.
  • Females aged 45 and older (with roughly 80% of enrolled subjects over the age of 50).
  • Presence of uterus.
  • AUB or PMB being worked up to diagnose the cause of the bleeding

排除标准

  • Investigator site staff members directly involved in the conduct of the study and their family members or subjects who are PinkDx, Inc. employees or their family members.
  • Other medical or psychiatric conditions that would increase the risk of study participation in the judgement of the Investigator.
  • Women who have had a hysterectomy.
  • Women with a known history of endometrial cancer or uterine sarcoma.
  • Women who have received prior treatment for endometrial cancer.
  • Inability or unwillingness to sign informed consent.
  • Clinical suspicion of pregnancy.
  • Women who have used a tampon within 7 days of sample collection.

研究组 & 干预措施

Benign

sample collection from females with benign causes of AUB/PMB

Malignant

sample collection from females with malignant causes of AUB/PMB

结局指标

主要结局

Sensitivity

时间窗: 12 months

ability to detect cancer

次要结局

  • Specificity(12 months)

研究者

发起方
PinkDx, Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (27)

Loading locations...

相似试验